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Background: Polymyxin is a cationic polypeptide antibiotic that can disrupt bacterial cell membrane by interacting
with its lipopolysaccharide molecules and is used as a last resort drug against lethal infections by the carbapenem-
resistant superbugs (like NDM-1). However, global discovery of the MCR-1 colistin resistance dramatically challenges
the newly renewed interest in colistin for clinical use.
Methods: The mcr-1-harboring plasmids were acquired from swine and human Escherichia coli isolated in China,
from 2015 to 2016, and subjected to Illumina PacBio RSII and Hi-Seq2000 for full genome sequencing. PCR was
applied to close the gap of the assembled contigs. Ori-Finder was employed to predict the replication origin (oriC)
in plasmids. The phenotype of MCR-1-producing isolates was evaluated on the LBA plates with various level of
colistin. Genetic deletion was used to test the requirement of the initial “ATG” codon for the MCR-1 function.
Results: Here, we report full genomes of over 10 mcr-1-harboring plasmids with diversified replication incompatibilities.
A novel hybrid IncI2/IncFIB plasmid pGD17-2 was discovered and characterized from a swine isolate with colistin
resistance. Intriguingly, co-occurrence of two unique mcr-1-bearing plasmids (pGD65-3, IncI2, and pGD65-5, IncX4) was
detected in a single isolate GD65, which might accelerate dissemination of the mcr-1 under environmental selection
pressure. Genetic analyses of these plasmids mapped mobile elements in the context of antibiotic resistance
and determined two insertion sequences (ISEcp1 and ISApl1) that are responsible for the mobilization of
mcr-1. Gene deletion also proved that the first ATG codon is redundant in the mcr-1 gene.
Conclusions: Collectively, our results extend landscapes of the diversified mcr-1-bearing plasmid reservoirs.
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Antibiotics play crucial roles in controlling the dissemin-
ation of lethal infections by bacterial pathogens. How-
ever, the emergence of antibiotic resistance is developing
a great threat to public health worldwide. It is estimated
that multidrug-resistant (MDR) pathogens cause nearly
700,000 cases of lethal infections (including 214,000
neonatal deaths) each year [1]. The discovery of New
Delhi β-lactamase 1 (NDM-1) and its variants like
NDM-5 had ever pushed us on the cusp of post-
antibiotic era, in that they can confer potent resistance
to extended spectrum β-lactamases (ESBL) and carba-
penems, the two classes of widely used antibiotics* Correspondence: fengyj@zju.edu.cn
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(http://creativecommons.org/publicdomain/zeagainst the MDR bacteria [2, 3]. In general, the cationic
polypeptide antibiotic polymyxin E (colistin) is believed
to act as a last resort against fatal infections by gram-
negative pathogens with pan-drug resistance [4, 5].
However, it seems likely that gut bacteria have evolved
some mechanisms to bypass the final line of refuge anti-
biotic (i.e., colistin resistance) [4–7]. Biochemical mech-
anism by which bacteria acquire the appreciable
resistance to colistin is mainly dependent on the reduc-
tion in the net negative charge of the bacterial outer-
membrane, which consequently decreases the binding
affinity of colistin to bacterial surface [8–10]. To the best
of our knowledge, four types of modifications of the lipid
A moiety anchored on bacterial lipid polysaccharide
(LPS) are involved in the alteration of the net negative
surface charge, which include (i) modification at 3′-
linked second fatty acyl chain with glycine (and/orle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Wang et al. Microbiome  (2017) 5:70 Page 2 of 9diglycine) [8]; (ii) the addition of amino-arabinose to 4′-
phosphate position of sugar [9]; (iii) the addition of
sugar with phosphoethanolamine (pEtN) at 4′-phos-
phate position [10, 11]; and (iv) the attachment of galact-
osamine (GalN) to 1′-phosphate of sugar [12, 13].
Unlike the fact that a single ArnT enzyme catalyzes the
reaction for amino-arabinose-based sugar modification
of lipid A in Pseudomonas aeruginosa (P. aeruginosa)
[14] and Cupriavidus metallidurans [9], a three-
component system (AlmG-AlmF-AlmE, encoded by an
operon of Vc1577-Vc1578-Vc1579) is evolved to modify
the lipid A with glycine in Vibrio cholerae [8]. The pEtN
modification of lipid A originally found in Klebsiella
pneumoniae (K. pneumoniae) is attributed to the point
mutations of the phoP-phoQ two-component system and
its regulator gene mgrB [11]. Intriguingly, the modifica-
tions of lipid A with both GalN and pEtN account for
colistin resistance in the serious opportunistic pathogens
Acinetobacter baumannii (A. baumannii) [13, 15]. Add-
itionally, the PmrA/PmrB two-component system is also
implicated into genetic control of lipid A modification as
well as polymyxin resistance in Salmonella enterica (S.
enterica) [16], A. baumannii, and P. aeruginosa [14].
Thus, we anticipated that enteric pathogens have devel-
oped multiple mechanisms to remodel its lipid A struc-
ture/integrity on the LPS under dynamic selection by
the altered environments, like antibiotic exposures.
The emergence of the mobilized colistin resistance
gene (mcr-1) illustrated a new mechanism for plasmid-
borne polymyxin resistance [6]. The protein product of
mcr-1, referred to MCR-1, is annotated as an integral
membrane protein with five trans-membrane helices [7].
Our genetic experiment proved that localization of the
MCR-1 in bacterial peri-plasm is critical for its role in
colistin resistance through deleting the trans-membrane
region [7]. Together with catalytic structures of MCR-1
reported by three other research groups [17–19], our
structure-guided functional studies revealed the require-
ment of a five-residue-containing motif for its biochem-
ical function [7]. Since its first discovery in Southern
China in the late of 2015 [6], the mcr-1 gene have been
detected in nearly 40 countries from five of seven conti-
nents [7, 20]. The mcr-1-positive gut bacteria included
Escherichia coli (E. coli) [21, 22], S. enterica [23, 24], K.
pneumoniae [6, 25, 26], Enterobacter aerogenes (E. aero-
genes) [27], Kluyvera ascorbata [28], Citrobacter freundii
[29], and Citrobacter braakii [30]. Not only does the
mcr-1 gene appear in diversified E. coli isolates with
different sequence types [20, 31], but also it coexists
with the NDM-1 [32, 33] and its variants, like NDM-5
[34, 35] and NDM-9 [36]. Additionally, ESBL can be
coproduced with MCR-1 from a single plasmid or a
same bacterial isolate [37–39]. Further sequence analyses
showed that the mcr-1-harboring plasmid reservoirsexhibit an unexpected diversity [20–22]. Multiple lines
of replication incompatibility have been assigned to
these mcr-1-bearing plasmids, which included IncP [26],
IncI2 [6, 23, 24, 35, 40, 41], IncX1-X2 mosaic version
[42], IncX3-X4 hybrid type [43], IncX4 [7, 44, 45],
IncHI2 [23, 24, 35, 46], IncFI [47], IncFII [48], and
IncHI1 [49], respectively. Obviously, it seems likely that
the spread of mcr-1 proceeds by complex dissemination
across diversified species among Enterobacteriaceae.
Our recent study suggested that a group of mcr-1-
positive plasmids with distinct backbones are present in
swine farm E. coli isolates as well as human clinical E.
coli isolates [20]. Here, we report comparative genomics
of over 10 representative mcr-1-bearing plasmids. Unex-
pectedly, we identified a new mcr-1-carrying hybrid plas-
mid pGD17-2 classified into two different replication
incompatibilities (IncFIB and IncI2). Moreover, we are
first to observe coexistence of two unique mcr-1-positive
plasmids (IncI2-type pGD65-3 and IncX4-like pGD65-4)
in a same E. coli isolate. In addition, we determined a
couple of variants of the other known mcr-1-positive
plasmids. These findings expand greatly the landscape of
mcr-1-harboring plasmids.
Methods
Conjugation, S1-PFGE, and Southern hybridization
The mcr-1-positive samples we obtained were kept in
LB broth or on LB agar with appropriate antibiotics. E.
coli C600 was used as the recipient for the conjugation
experiment of MCR-producing E. coli isolates. The
trans-conjugants were selected on MacConkey agar con-
taining colistin (2 μg/ml) and streptomycin (2000 μg/ml)
and finally confirmed by PCR and ERIC-PCR. To
analyze the location of the mcr-1 gene, S1-PFGE and
Southern blot analysis were performed using the original
strains and trans-conjugants carrying mcr-1 gene.
Briefly, whole-cell DNA of the E. coli strains were
extracted and embedded in agarose gel plugs. Subse-
quently, the agarose gel plugs were treated with S1
nuclease (TaKaRa, Dalian, China), and the DNA frag-
ments were separated by PFGE. Southern blot
hybridization was then performed with the digoxigenin-
labeled probes (Roche Diagnostics, Mannheim, Germany)
specific for the mcr-1 gene.
Bacterial samples, plasmid sequencing, and sequence
assembly
The plasmids and primers used in this study are listed in
Additional file 1: Tables S1 and S2. Fourteen plasmids
were sequenced by Illumina PacBio RSII and Hi-
Seq2000 using prepared paired-end 2 × 200-bp libraries,
of which raw data were separately assembled using
SOAP de novo (version 2.0.4) and SMRT Analysis (ver-
sion 2.2.0), after high-quality read acquisition, and any
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PCR. The finally generated contigs were checked for
circularization, whereas overlapping ends were trimmed.
The general features of the 14 plasmids are summarized
in Additional file 1: Table S1. Ori-Finder was employed
to predict the replication origin (oriC) in plasmids under
study [50]. The assembled plasmid sequences were an-
notated by using the RAST suite for the identification of
protein-coding sequences, and ARAGORN [51] for
tRNA, and RNAmmer [52] for rRNA.
Annotation of plasmids and resistance genes
A bacterial mobilome annotation procedure [53] was
designed to type sequenced/assembled plasmids and
to identify insertion sequences (ISs), integrons, and
prophages. The mcr-1 gene has been proposed to
confer colistin resistance, while other mobile-related
elements were detected using specific informatics
tools. PlasmidFinder [54] was used to type replicons
of plasmids that had been previously assembled and
identified. ISs were mainly identified with ISsaga [55]
and ISfinder [56] and then manually adjusted with focuses
on intactness, terminal inverse repeats (IRs), and flanking
direct repeats (DRs). ISCR elements were also identified
(http://www.cardiff.ac.uk/research/explore/research-units/
antibacterial-agents-and-genetics-of-resistance). Prophages
were predicted with PHAST [57] and Phage_Finder [58].
Resistance genes were in silico identified with ARDB [59],
CARD [60], and ResFinder [61].
Determination of colistin resistance
According to the recommendation of EUCAST, micro-
broth dilution method was used to address colistin MIC,
whose level of ≤0.25 μg/ml was treated susceptible. For
functional evaluation of mcr-1 derivatives in colistin re-
sistance, agar dilution method was applied and resist-
ance level of the colistin-susceptible strain MG1655
(≤2.0 μg/ml) is the cutoff value.
Nucleotide sequence accession number
The plasmid nucleotide sequences reported in this study
have been deposited in GenBank under accession num-
ber listed in Additional file 1: Table S1.
Results and discussion
Genetic evidence for the presence of mcr-1 in diversified
plasmids
Our recent study reported hundreds of mcr-1-positive
plasmids through extensive dissection of a thousand of E.
coli isolates from swine farm and hospitalized patients,
which implied that the diversified mcr-1-carrying plasmids
are present [20]. In this follow-up study, 13 representative
mcr-1-positive plasmids (Additional file 1: Table S1) were
subjected to further genetic analyses of both S1-pulsed-field gel electrophoresis (PFGE) (Additional file 2: Figure
S1A and C) and Southern hybridization blot (Additional
file 2: Figure S1B and D). As expected, diversified plasmids
were present in the above 13 E. coli isolates (Additional
file 2: Figure S1). Of note, ten trans-conjugants were
successfully obtained from the 13 mcr-1-positive isolates.
Southern blotting revealed that the mcr-1 gene was
present on plasmids ranging from ~33 to 240 kb
(Additional file 2: Figure S1). First, it was estimated that
no less than three isolates (GD46, GD65, and WH03) car-
ries the mcr-1-positive plasmid of ~33 kb long (Additional
file 2: Figure S1B and D). Second, the mcr-1 gene is
located on ~60 kb plasmid in seven isolates (Additional
file 2: Figure S1B and D). Third, two big mcr-1-harboring
plasmids (~120 kb for pGD17-2 and ~240 kb for pGD80-
2) separately occurred in the strains GD17-2 and GD80-2
(Additional file 2: Figure S1B and D). Although we failed
to detect mcr-1-positive band in the strain Lishui12 using
Southern blot (Additional file 2: Figure S1B), we proved
that it is PCR-positive for mcr-1, and had a success in iso-
lating a mcr-1-producing plasmid pLishui12 of ~33 kb
long (Additional file 2: Figure S4). Curiously, in the strain
GD65, the mcr-1 gene was found on two distinct plasmids
with different sizes (~30 kb for pGD65-4 and ~60 kb for
pGD65-3, Additional file 2: Figure S1B). The physical evi-
dence for the presence of mcr-1 in the above plasmids was
validated by further PCR analyses combined with direct
DNA sequencing. All the above mcr-1-positive plasmids
can confer the E. coli strains to possess modest level of
colistin MIC [2–4 μg/ml] (Table 1).
Overall landscape of the mcr-1-carrying plasmids
In total, full replicon sequences of 13 mcr-1-harboring
plasmids were assembled through Hi-Seq sequencing
(Illumina Inc.), in which the gaps were closed with ABI
3730 Sanger sequencing (Additional file 1: Table S1).
Using specific primers (Additional file 1: Table S2), all
these plasmids were confirmed by the close-loop PCR
(Additional file 2: Figure S8A). BLAST-based query
using PlasmidFinder (https://cge.cbs.dtu.dk/services/
PlasmidFinder/) revealed that the newly-determined 14
plasmids are classified into four types as follows: eight
IncI2-type plasmids, four IncX4-like plasmids, one
IncHI2-type, and one IncI2/IncFIB hybrid plasmid
pGD17-2 (Additional file 1: Table S1 and Additional file 2:
Figures S1-S7). It is noted that (i) the insertion sequence
ISApl1 is located immediately upstream of the mcr-1 gene
(Figs. 1 and 2) and (ii) a putative locus pap2 encoding the
PAP2-family protein is neighbored with the downstream
of the mcr-1 gene (Fig. 2), which might facilitate the trans-
fer of mcr-1 [39]. We also noted that the insertion se-
quence of ISApl1 is lacking in some cases, implying a relic
for frequent conjugation of ISApl1-mcr-1-pap2. Therefore,
the discovery of these plasmids significantly contributed
Table 1 Colistin MIC of clinical E. coli strains expressing mcr-1
Strains
Colistin MIC (μg/ml) GD17 GD65 GD80 GD23 GD53 LS142 WH07 WH09 WH13 GD81 LS12 GD46 WH03
2 4 4 2 2 4 4 4 4 2 4 4 4
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known replicon sequences (Additional file 1: Table S3).
Briefly, in similarity to the newly identified plasmid
pLishui142-1 (61.908 kb), seven additional new members
of IncI2-type mcr-1-bearing plasmids were determined
in this study, which corresponded to pGD23-3
(64.078 kb), pGD53-3 (62.813 kb), pGD65-3 (64.857 kb),
pGD81-1 (62.712 kb), pWH07-3 (62.067 kb), pWH09-3
(62.072 kb), and pWH13-4 (60.694 kb), respectively
(Additional file 1: Table S1). Although this type of plasmids
lacks the insertion sequence ISApl1 (Additional file 2:
Figure S2), they consistently share a site-specific recombin-
ase (rci) gene, two pilus-encoding genes (pil and tra), and
four different pilli proteins (Additional file 2: Figure S2). In
addition, we found that heterogeneity of whole-shufflon
structural variations exists between the 3′ region of pilV
gene and rci gene in mcr-1-harboring IncI2 plasmids as re-
cently reported [62]. The plasmid sequences yielded the
following results: in pWH9-3 and pWH7-3, rci-A-A′-C-C
′-B′-D′-pilV; in pWH13-4, rci-A-A′-C-C′-D′-B′-pilV; in
LS142-1, rci-B′-D′-A-A′-pilV; in 65-3, rci-A′-A-D′-B′-C-
C′-B′-D′-A-A′-pilV; in pGD23-3, rci-C-C′-D′-B′-A′-A-B
′-D′-pilV; in pGD53-3, rci-C-C′- B′-D′-D′-B′-A′-A-pilV;
and in hybrid plasmid pGD17-2, rci-C-C′-A-A′-D′-B
′-pilV. Unlike the scenario seen with the IncHI2 plasmid
pHNSHP45-2 that carries the mcr-1 gene [46], the typical
mcr-1 cassette is located in different locations of pGD80-2Fig. 1 Discovery of a new hybrid plasmid pGD17-2 that comprises the mcr
compared with the counterpart of pHNSHP45 and pHUSEC2011-2. The mo
resistant strain GD17. The mcr-1-positive IncI2-type plasmid pHNSHP45 and
the plasmid backbone of pGD17-2, giving the presence of two incompatib
also shown to highlight the syntenic regions. Regions of synteny between ad
are drawn to scale. Genes associated with the tra and pil loci are indicated by
blue arrows. The mcr-1 gene is indicated with the red arrow, while accessory g
in green arrows(241.033 kb), a member of the IncHI2-type plasmid family
(Additional file 2: Figure S3). Moreover, it encodes three
more resistance genes (aph(3′)-Ia, oqxAB, and tetR), sug-
gesting complexity/flexibility among the mcr-1-bearing
IncHI2 plasmids.
In addition to pLishui12 (33.309 kb) [63], three
more mcr-1-harboring IncX4 plasmids we reported
here included pGD46-3 (33.302 kb), pGD65-4
(33.305 kb), and pWH03 (33.292 kb), respectively
(Additional file 1: Table S1). All the four IncX4 plas-
mids are featuring the almost identical genetic back-
bone in which no ISApl1 element is flanked by the
only antibiotic resistance gene mcr-1 gene (Additional
file 2: Figures S4, S5, and S7). Genome alignments in-
dicated that plasmid pGD46-3 was nearly identical to
the plasmid pMCR1_IncX4 (Accession no.: KU761327
from K. pneumoniae in China). It seems likely that
pGD46-3 might be generated through the integration
of the mcr-1 gene into the specific site between the
pir and parA genes of IncX4-type pSH146_32 plasmid
(Additional file 2: Figure S5).
Discovery of a new mcr-1-positive hybrid plasmid
pGD17-2
The novel mcr-1-positive plasmid pGD17-2 we deter-
mined (Fig. 1 and Additional file 1: Table S1) allows the
strain GD17 to grow well on the LBA plate-1 gene. The full genome of pGD17-2 is sequenced and collinearly
saic plasmid pGD17-2 (highlighted in purple) is isolated from a colistin-
the mcr-1-negative plasmid pHUSEC2011-2 both are applied to define
le replicon types (IncFIB and IncI2). The relevant parts of plasmid are
jacent schematics are indicated by the shaded areas. These schematics
light blue arrows, while replication-associated genes are denoted as dark
enes are indicated by black arrows. Insertion sequences are highlighted
Fig. 2 Co-existence of two distinct incompatible mcr-1-bearing plasmids (pGD65-3 and pGD65-4) in a single colistin-resistant E. coli isolate GD65.
a Cartoon diagram for the two mcr-1-positive plasmids (pGD65-3 and pGD65-4) that coexist in an E. coli isolate GD65. b Linear comparison of the
IncI2-type plasmid pGD65-3 with other two closely related mcr-1-harboring plasmids pHNSHP45 and pHN1122-1. c Linear genome alignments of
the IncX4-type plasmid pGD65-4 with other two closely related mcr-1-bearing plasmids pMCR1_IncX4 and pSH146_32. Regions (>99% similarity)
are marked by green shading. Genes associated with the tra and pil loci are separately indicated by light blue arrows, while replication-associated
genes are denoted as dark blue arrows. The mcr-1 genes are highlighted in red, while insertion sequences are in green arrows
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file 2: Figure S9). The plasmid size of pGD17-2 is
121.454 kb (Additional file 1: Table S1), whose GC% is
43.69%. To rule out the possible errors in plasmid se-
quencing or assembly, hybrid plasmid pGD17-2 was fur-
ther confirmed by subsequent PCR analysis and Sanger
sequencing (Additional file 2: Figure S8 A and B). Com-
parative genomics revealed that pGD17-2 is a new hy-
brid one featuring with two types of plasmid backbones
(IncI2 and IncFIB, in Fig. 1), implying temporary transi-
tion status of mcr-1 transmission or genetic stabilityunder special selection pressure. Relative to the para-
digm mcr-1-harboring IncI2-type plasmid pHNSHP45,
pGD17-2 exhibited 51% coverage and 99% identity and
possessed two insertion sequences (IS629 and IS1294) in
the nikB gene, as well as an additional IS629-mediated
insertion sequence (~56 kb) in the pilO gene (Fig. 1 and
Additional file 2: Figure S2). Further sequence align-
ments suggested that the above insertion sequence
(~56 kb) has only 26% coverage to a mcr-1-negative
plasmid pHUSEC2011-2 (Accession no.: HE610901)
(Fig. 1 and Additional file 2: Figure S2). Notably, the
Fig. 3 Scheme for the complexity in diversified mcr-1-bearing
plasmids. The mcr-1-carrying plasmids are denoted with circles, in
which the mcr-1 gene is highlighted with red arrow. To the best of
our knowledge, no less than ten families of plasmids produce the
MCR-1 protein. Four types of mcr-1-containing plasmids are labeled
in color, corresponding to IncX4 (in green), IncI2 (in purple), IncHI2
(in orange), and the hybrid version of IncI2-IncFIB (in blue), respectively
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plasmid are highly related to the cognate conjugation-
associated counterparts or remnants (a syntenic F-like
or R-like type IV secretion system gene clusters and a
relaxase gene traI (Fig. 1 and Additional file 2: Figure
S2). In comparison with all the mcr-1-carrying plasmids
(Additional file 1: Table S3), pGD17-2 represents a new
hybrid plasmid producing MCR-1 colistin resistance.
Co-occurrence of two unique mcr-1-harboring plasmids
(pGD65-3 and pGD65-4) in a single E. coli isolate
Unexpectedly, two mcr-1-bearing plasmids namely
pGD65-3 and pGD65-4 (Fig. 2a and Additional file 2:
Figure S1) were localized onto a single E. coli strain
GD65 with significant colistin resistance (Additional file
2: Figure S9). The co-occurrence of these two plasmids
was experimentally validated with Southern blot
(Additional file 2: Figure S1B). Sequencing results
showed that pGD65-3 (33.301 kb in length) is an IncI2-
type plasmid, whereas the other one pGD65-4
(64.852 kb in length) is featuring a IncX4-type plasmid
backbone. In similarity to all the other known IncI2-type
plasmids, no insertion sequence ISApl1 is neighbored
with the mcr-1 gene in the pGD65-3 plasmid (Fig. 2b
and Additional file 2: Figure S6). Although the IncX4-
like plasmid pGD65-4 lacks the ISApl1 insertion
sequence in front of the mcr-1, but it retains pap2 at the
3′-end of the mcr-1 locus (Fig. 2c, Additional file 2:
Figures S4, S5 and S7). Conjugation-based PCR detec-
tion experiments demonstrated that the two plasmids
(pGD65-3 and pGD65-4, in Fig. 2) can be separately
transferred from the donor strain E. coli GD65
(Additional file 2: Figure S8C) to the recipient E. coli
strain C600 (Additional file 2: Figure S8D) and give ap-
preciable level of resistance to colistin (~16 μg/ml). To-
gether, this result defined a paradigm for coexistence of
two unique mcr-1-harboring plasmids (pGD65-4, IncX4
type, and pGD65-3, IncI2 type) in a single E. coli isolate.
Conclusions
The data presented here extends landscapes of mcr-1-
positive plasmids and highlights complexity of MCR-1
colistin resistance in gut microbiota (Fig. 3). Unlike the
scenarios seen with the first reported mcr-1-harboring
plasmid pHNSHP45, there are no ISApl1 element in
front of the mcr-1 gene in all the eight IncI2 plasmids
we reported (pGD23-3, pGD53-3, pGD65-3, pGD81-1,
pLishui142-1, pWH07-3, pWH09-3, and pWH13-4, in
Additional file 2: Figure S7A). It is noted that all the
IncI2 plasmids consistently contain a plasmid-borne
site-specific recombinase gene, rci (Additional file 2:
Figure S7A). Variations exist in the 3′-end sequence of
pap2 gene on IncI2 plasmids, of which the three plas-
mids (pWH07-3, pWH09-3, and pWH13-4) are almostthe same and the other three plasmids (pGD23-3,
pGD53-3 and pGD65-3) are highly identical (Additional
file 2: Figure S7A). By contrast, the mosaic plasmid
pGD17-2 is more flexible, with IS629 and IS1294 inser-
tion in the nikB gene. And ISApl1 immediately appears
in front of mcr-1 in pGD17-2. Thus, the hybrid plasmid
pGD17-2 represents a novel mobile element carrying
mcr-1 and provides remarkable insights into the
plasmid-mediated transfer of MCR-1 colistin resistance.
In the mcr-1-harboring IncX4 plasmids (pGD46-3,
pGD65-4, Lishui12, and pWH03), the regions between
parA gene and repA gene are nearly identical
(Additional file 2: Figure S7B), in that they shared 99%
similarity to IncX4 mcr-1-harboring K. pneumoniae plas-
mid pMCR1_IncX4 (Accession no.: KU761327). In com-
parison with the IncX4 plasmid pSH146_32, the mcr-1
gene was found to be inserted in the same location. Differ-
ent with mcr-1-harboring IncI2 plasmids, the 3′-end
sequences of pap2 are consistently present in IncX4 plas-
mids. In addition, no ISApl1 elements were found to flank
the mcr-1 gene (Additional file 2: Figure S7B). The fact
that strain GD65 carries two mcr-1-positive plasmids
(pGD65-3 and pGD65-4) might represent a first example
that both IncI2-type plasmid pGD65-3 and IncX4-type
plasmid pGD65-4 contributed to colistin resistance in E.
coli. Retrospectively, the two mcr-1-harboring plasmids
(IncI2-like plasmid pHNSHP45 [6] and IncHI2-type plas-
mid pHNSHP45-2 [46]) from the E. coli strain SHP45
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the coexistence of two different mcr-1-positive plasmids
does not confer distinguishable ability of the recipient
strains in colistin resistance when compared with the
strain with a single mcr-1-plasmid (Additional file 2:
Figure S9). In general, two successive ATG codons initiate
the mcr-1 gene in most of the cases like GD17 and GD65.
However, we noted that only one ATG in the case of
strain Lishui142 (abbreviated as LS142). We therefore
tested the function of this mcr-1 variant [referred to mcr-
1(Δ1)] using the pBAD24 expression system (Additional
file 2: Figure S9). In fact, it gave indistinguishable ability
when compared to the normal version mcr-1 in the trials
of colistin resistance, suggesting the redundancy of one
“ATG” codon in the MCR-1.
In summary, no less than ten types of plasmids medi-
ate the transmission of MCR-1 colistin resistance in field
and clinical isolates (Fig. 3). Our results extended signifi-
cantly our understanding of diversified mcr-1-bearing
plasmids, whose dissemination constitutes a potential
threat to public health and clinical treatment. Global dis-
tribution of mcr-1 in E. coli populations emphasizes the
importance to prevent global over- and/or mis-use of
colistin. Extensive surveillance programs of antibiotic re-
sistance should be extended to swine farms, and even in
human medicine, since mcr-1 has been recently identi-
fied in human isolates. Restrictive/rational use of colistin
is urgently required to prevent the rapid spread of mcr-1
to other bacteria and in different niches, excluding hu-
man hospitals and foodborne settings.Additional files
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